Genes tech (08257) releases mid-term performance results, with shareholders' attributable net profit of 38.703 million New Taiwan dollars, a decrease of 49.47% compared to the same period last year.

Zhitong Finance · Aug 14 19:24

Genes Tech (08257) announced its interim results for the six months ending June 30, 2024, during which time the group achieved...

According to the Zhixun Finance and Economics app, for the six months ending June 30, 2024, Genes Tech (08257) reported revenue of 0.535 billion New Taiwan dollars, a year-on-year decrease of 28.62%; shareholders' net profit was 38.703 million New Taiwan dollars, down 49.47% year-on-year; and basic earnings per share were 3.87 New Taiwan dollars.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

靖洋集团(08257)发布中期业绩 股东应占溢利3870.3万新台币 同比减少49.47%

Genes tech (08257) releases mid-term performance results, with shareholders' attributable net profit of 38.703 million New Taiwan dollars, a decrease of 49.47% compared to the same period last year.

Risk Disclaimer

Statement

靖洋集团(08257)发布中期业绩股东应占溢利3870.3万新台币同比减少49.47%